Insider Transactions in Q1 2021 at Pacific Biosciences Of California, Inc. (PACB)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 26
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
234,246
-5.71%
|
$7,495,872
$32.06 P/Share
|
|
Feb 26
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
234,246
+7.13%
|
$1,405,476
$6.29 P/Share
|
|
Feb 25
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
339,377
-5.37%
|
$11,199,441
$33.42 P/Share
|
|
Feb 25
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
339,377
+9.53%
|
$2,036,262
$6.29 P/Share
|
|
Feb 24
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
266,427
-6.59%
|
$9,591,372
$36.96 P/Share
|
|
Feb 24
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
266,427
+6.13%
|
$1,598,562
$6.25 P/Share
|
|
Feb 23
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
373,321
-5.02%
|
$12,319,593
$33.96 P/Share
|
|
Feb 23
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
373,321
+6.5%
|
$1,866,605
$5.53 P/Share
|
|
Feb 22
2021
|
Eric Schaefer Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,842
-4.16%
|
$149,838
$39.2 P/Share
|
|
Feb 22
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
229,127
-4.66%
|
$8,935,953
$39.15 P/Share
|
|
Feb 22
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
229,127
+4.46%
|
$1,145,635
$5.53 P/Share
|
|
Feb 16
2021
|
Susan G. Kim Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,300
+3.87%
|
-
|
|
Feb 16
2021
|
Christian O Henry Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+1.92%
|
-
|
|
Feb 16
2021
|
Eric Schaefer Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,050
+5.19%
|
-
|
|
Feb 16
2021
|
Kathy Ordonez Director |
SELL
Open market or private sale
|
Direct |
220,771
-45.05%
|
$10,597,008
$48.35 P/Share
|
|
Feb 16
2021
|
Kathy Ordonez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
185,879
+17.03%
|
$929,395
$5.18 P/Share
|
|
Feb 12
2021
|
William W. Ericson Director |
BUY
Other acquisition or disposition
|
Direct |
68
+50.0%
|
-
|
|
Feb 12
2021
|
William W. Ericson Director |
SELL
Other acquisition or disposition
|
Indirect |
750,000
-13.4%
|
-
|
|
Feb 12
2021
|
David Botstein Director |
SELL
Open market or private sale
|
Direct |
160,000
-98.39%
|
$7,840,000
$49.85 P/Share
|
|
Feb 12
2021
|
David Botstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
160,000
+24.97%
|
$640,000
$4.58 P/Share
|
|
Feb 12
2021
|
Randall S Livingston Director |
SELL
Open market or private sale
|
Direct |
67,500
-100.0%
|
$3,240,000
$48.07 P/Share
|
|
Feb 12
2021
|
Randall S Livingston Director |
BUY
Exercise of conversion of derivative security
|
Direct |
67,500
+38.02%
|
$270,000
$4.98 P/Share
|
|
Feb 12
2021
|
Lucy Shapiro Director |
SELL
Open market or private sale
|
Direct |
101,666
-100.0%
|
$5,083,300
$50.4 P/Share
|
|
Jan 25
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
125,406
-3.33%
|
$4,514,616
$36.53 P/Share
|
|
Jan 25
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
125,406
+11.41%
|
$752,436
$6.14 P/Share
|
|
Jan 22
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
150,857
-5.3%
|
$5,430,852
$36.8 P/Share
|
|
Jan 22
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
150,857
+13.12%
|
$905,142
$6.14 P/Share
|
|
Jan 21
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
258,521
-3.67%
|
$9,565,277
$37.08 P/Share
|
|
Jan 21
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
208,711
+8.75%
|
$834,844
$4.21 P/Share
|
|
Jan 20
2021
|
Michael Hunkapiller Director |
SELL
Open market or private sale
|
Direct |
215,026
-5.11%
|
$8,601,040
$40.06 P/Share
|
|
Jan 20
2021
|
Michael Hunkapiller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
215,026
+16.19%
|
$430,052
$2.27 P/Share
|
|
Jan 08
2021
|
Mark Van Oene Officer |
BUY
Grant, award, or other acquisition
|
Direct |
335,000
+50.0%
|
-
|
|
Jan 08
2021
|
Peter Fromen Officer |
BUY
Grant, award, or other acquisition
|
Direct |
160,000
+50.0%
|
-
|